Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Essential Hypertension Article
This is a selection made from among articles on Drug Treatment Essential Hypertension. For a permanent link to this article, or to bookmark it for future reading, click here.
Drug Rehabilitation: The Key Component
from:by Jay B Stockman
Drug and alcohol use can be traced back to 4000 B.C., in Egypt. By the 19th century, active substances were being extracted from the raw materials, and these psychoactive substances were being sold without any regulations. By the early 1900s there were an estimated 250,000 drug addicts in the United States. The anti-war upheaval of the 1960s brought with it a dramatic increase in drug use and increased social acceptance. The 1980s saw a decline in most drug use, with a slight increase in Cocaine use. Despite this overall decline, most Americans still regard illegal drug use as one of the nation's most serious problems. Opinion polls show the public favors a variety of different approaches to the drug problem. In addition to strict laws, it is vital to effectively treat individuals already suffering from drug dependence and substance abuse, through education, therapy, medicine, and group support. Drug rehabilitation is a key component to a successful campaign against the use of illegal drugs. At its fundamental level, humans use substances such as alcohol and psychoactive drugs because these substances give the user a feeling of pleasure. Pleasure is a very powerful force. Our brains are wired in such a way that if you do something that gives you pleasure you will probably want to do it again. All drugs that are addicting can energize and enhance the brain's pleasure circuit. Addiction is a chronic disease that affects ones brain, and ones behavior. Addicted individuals abuse drugs without regard to the consequences of health, relationships, money, work etc. It is a consuming disease that not only effects the individual directly, but others indirectly. If left untreated, this disease can lead to the social death, as well as the actual death of the inflicted individual. Proper management must be instituted immediately to return the individual to a life that is more manageable, and drug free. A program of drug rehabilitation best achieves this goal. Drug rehabilitation is the process of medical or psychotherapeutic treatment for substance abuse. The goal of any drug rehabilitation program is to provide comprehensive drug treatment and alcohol rehabilitation services, and introduce individuals to a new lifestyle free of chemicals. Successful treatment of substance abusers depends upon the severity and nature of the addiction, as well as motivation. Some treatment programs use medicines that neutralize the effects of the drug. Acupuncture has also been successful in treating the cravings that accompany drug withdrawal. Comprehensive substance abuse counseling and education is another component for a successful plan. Evaluating the efficacy of any treatment plan is difficult because of the chronic nature of drug abuse, and the fact that the disease is usually complicated by personal, social, and health factors. Statistics show that getting sober is easy; staying sober is the hard part, and the first year of recovery is the most difficult. It may take a number of attempts before success is achieved. Nobody chooses to become a drug addict or alcoholic, this disease cannot be wished away, it has to be treated.
Jay B Stockman is a contributing editor for Drug Rehab Programs Visit newdrug-rehab-center.com/ for more information.
Drug Treatment Essential Hypertension Specific links
Drug Treatment Essential Hypertension News
Plan to Cure Alzheimer's Affects Decisions Now
With appropriate fanfare, a national Alzheimer's plan was announced last week. Its goal is nothing less than to find prevention and treatment approaches for the devastating illness by 2025. That's a very ...
Read more...European expert presents new guidelines for cardio care
Global healthcare leader MSD invited guest speaker Alberico Catapano, chairman of the European Atherosclerosis Society (EAS), to deliver a lecture on the topic “New Advances in Cardiovascular Risk Reduction in High-Risk Patients” at the 17th Joint Annual Convention of the Philippine Society of Hypertension and Philippine Lipid and Atherosclerosis Society at the Crowne Plaza Hotel.
Read more...ArQule and Daiichi Sankyo Announce Completion of Patient Recruitment in Phase 3 Clinical Trial of Tivantinib in Non ...
ArQule, Inc. and Daiichi Sankyo, Co., Ltd. today announced that recruitment of patients has been completed in the randomized, double-blind, controlled Pha
Read more...Studies examine potential treatments for UC, hep C and other gastrointestinal conditions
New research being presented at Digestive Disease Week® (DDW) reveals effective treatments for a number of gastrointestinal conditions, which are often chronic and costly.
Read more...New research reveals effective treatments for gastrointestinal conditions
New research being presented at Digestive Disease Week- (DDW) reveals effective treatments for a number of gastrointestinal conditions, which are often chronic and costly.
Read more...Failure to Take Medicine Linked to Unnecessary Hospital Visits, Especially for Medicare Patients Taking High Blood ...
ATLANTA, May 11, 2012 /PRNewswire/ -- Older patients with high cholesterol or high blood pressure are at particular risk for unnecessary hospitalizations if they don't follow doctor's orders on taking ...
Read more...Pluristem's CEO Letter to Shareholders
HAIFA, Israel -- Pluristem Therapeutics, Inc. today announces the below CEO letter to shareholders:
Read more...Cardiac Function in Pre-Clinical Diabetic Diastolic Heart Failure Subjects Improved by Pluristem's PLX Cells
HAIFA, Israel -- Pluristem Therapeutics, Inc. today announced that cardiac function in a diabetic-induced diastolic dysfunction in animals improved following PLacental eXpanded (PLX cells) administration. ...
Read more...China Pharma Holdings, Inc. Reports First Quarter 2012 Financial Results
HAIKOU CITY, China, May 15, 2012 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. (CPHI) ("China Pharma" or the "Company"), a specialty pharmaceuticals company ...
Read more...Compassionate Use of Pluristem's PLX Cells Saves the Life of a Child After Bone Marrow Transplantation Failure
HAIFA, Israel -- Pluristem Therapeutics, Inc. today announced that a seven year-old girl suffering from an aplastic bone marrow whose condition was rapidly deteriorating is now experiencing a reversal ...
Read more...